Next, we performed pairwise differential abundant species analysis to identify specific bacteria with potential clinical importance, focusing on the T2D‐NO group that had unique clinical characteristics (e.g., decreased insulin secretion) and microbiota composition. This evidence concerns the gene INS and type 2 diabetes mellitus.